ImmuCell Corporation (ICCC) Operating income 2016–2025
ImmuCell Corporation (ICCC) annual operating income history from SEC filings — each fiscal year as reported.
$1.6MFY2025 · since FY2016: $890,204 → $1.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.6M | +200.6% |
| FY2024 | -$1.6M | +71.5% |
| FY2023 | -$5.7M | -150.0% |
| FY2022 | -$2.3M | -993.2% |
| FY2021 | $257,385 | +118.6% |
| FY2020 | -$1.4M | -44.7% |
| FY2019 | -$953,908 | +34.1% |
| FY2018 | -$1.4M | -495.7% |
| FY2017 | -$242,845 | -127.3% |
| FY2016 | $890,204 | — |
Source: SEC XBRL filings · For reference only · Not investment advice